2370 Relative risk analysis of safety profile of lanreotide autogel/depot vs. placebo in patients with pancreatic and intestinal neuroendocrine tumours. (September 2015) - Phan, A.; Caplin, M.; Pavel, M.; Cwikła, J.; Raderer, M.; Sedláčková, E.; Cadiot, G.; Wolin, E.; Capdevila, J.; Wall, L.; Rindi, G.; Langley, A.; et al.